Skip to main navigation Skip to search Skip to main content

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

  • PJ Bingley
  • , EAM Gale
  • , Group European Nicotinamide Diabetes Intervebtion Trial (ENDIT)

    Research output: Contribution to journal › Article (Academic Journal) › peer-review

    106 Citations (Scopus)
    Translated title of the contributionProgression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk
    Original languageEnglish
    Pages (from-to)881 - 890
    Number of pages10
    JournalDiabetologia
    Volume49 (5)
    DOIs
    Publication statusPublished - May 2006

    Bibliographical note

    Publisher: Springer

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this